Pharmafutures

A quick overview

PharmaFutures is an investor-led dialogue that explores how to better align corporate profitability with improved access to innovative and affordable healthcare. Read more…

PharmaFutures has run since 2004 and is now in its fourth iteration – Shared Value.

Comment

The structured, two-way communication enabled by PharmaFutures helps to improve levels of trust, understanding and a greater alignment of interest between investors and pharmaceutical executives.

Daniel Summerfield, USS

Shared Value: Rebuilding Pharma's Contract with Society

Download executive summary

Download full report

PharmaFutures 4

PharmaFutures 4 explores the need for industry to reframe its social contract to ensure that market signals about unmet patient need and incentives for R&D are better aligned. Find out more
PharmaFutures 3

PharmaFutures 3 - Emerging Opportunities, explored the links between sustainable pharmaceutical business models and improved health outcomes in middle-income markets, including China, India and Brazil. Find out more
PharmaFutures 2

PharmaFutures 2 – Prescription for long term value, analysed the present operating environment rather than focusing on long-term futures. Find out more
PharmaFutures 1

The Pharmaceutical Sector: A Long-Term Value Outlook, addressed the dilemma of how to convince investors of ongoing profitability while simultaneously meeting changing and growing societal expectations. Find out more

A quick overview

Comment

Shared Value: Rebuilding Pharma's Contract with Society

PharmaFutures 4

PharmaFutures 3

PharmaFutures 2

PharmaFutures 1